Haleon/HLN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Haleon
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Ticker
HLN
Sector
Consumer Non-Cyclicals
Trading on
NYSE
Industry
Personal Care Products
Headquarters
Weybridge, United Kingdom
Employees
25,408
Website
www.haleon.com
Haleon Metrics
BasicAdvanced
$29B
Market cap
56.21
P/E ratio
$0.15
EPS
-
Beta
$0.08
Dividend rate
0.91%
Dividend yield
Price and volume
Market cap
$29B
Dividend rate
$0.08
Financial strength
Total debt to equity
57.421
Interest coverage (TTM)
5.74%
Management effectiveness
Valuation
Price to earnings (TTM)
56.21
Price to revenue (TTM)
5.39
Price to book
1.79
Price to tangible book (TTM)
-2.91
Dividend yield (TTM)
0.91%
Growth
Revenue change (TTM)
0.16%
Earnings per share change (TTM)
-2.43%
What the Analysts think about Haleon
Analyst Ratings
Majority rating from 2 analysts.
Haleon Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
£2.9B
5.53%
Net income
£423M
-14,200.00%
Profit margin
14.49%
-14,590.00%
Haleon Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Actual
£0.07
£0.10
-
Expected
£0.10
£0.09
£0.07
Surprise
-36.29%
17.39%
-
Haleon News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Haleon stock?
Haleon (HLN) has a market cap of $29B as of July 03, 2024.
What is the P/E ratio for Haleon stock?
The price to earnings (P/E) ratio for Haleon (HLN) stock is 56.21 as of July 03, 2024.
Does Haleon stock pay dividends?
Yes, the Haleon (HLN) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $0.0762 and the yield is 0.91%. Haleon has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Haleon dividend payment date?
The next Haleon (HLN) dividend payment date is unconfirmed.
What is the beta indicator for Haleon?
Haleon (HLN) does not currently have a Beta indicator.
Buy or sell Haleon stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.